|1.||Madamwar, Datta: 2 articles (01/2015 - 07/2009)|
|2.||Huang, Bei: 2 articles (12/2008 - 02/2002)|
|3.||Patel, Dipak K: 1 article (01/2015)|
|4.||Devkar, Ranjitsinh V: 1 article (01/2015)|
|5.||Desai, Swati N: 1 article (01/2015)|
|6.||Upadhyay, Kapil K: 1 article (01/2015)|
|7.||Bishop, Debbie: 1 article (05/2014)|
|8.||Guest, Alan: 1 article (05/2014)|
|9.||Kumpel, Belinda: 1 article (05/2014)|
|10.||Dixey, Jonathan: 1 article (05/2014)|
05/01/1999 - "We demonstrate our method by using it to study the equilibrium binding of a haptenated fluorescent protein, 2,4-dinitrophenol-coupled B-phycoerythrin (DNP25-PE), to fluorescein isothiocyanate-labeled anti-DNP IgE on the surface of rat basophilic leukemia cells. "
12/01/1985 - "The IgE receptors of RBL-2H3 rat basophilic leukemia cells were labeled with anti-dinitrophenol IgE (anti-DNP-IgE) and then cross-linked with multivalent ligands (DNP-bovine serum albumin [BSA]; DNP-B-phycoerythrin; DNP-BSA-gold). "
07/01/2009 - "In the present study, the protective role of purified C-phycoerythrin (C-PE) against diabetic complications and Cu-mediated lipoprotein oxidation was evaluated. "
07/01/2009 - "Attenuation of diabetic complications by C-phycoerythrin in rats: antioxidant activity of C-phycoerythrin including copper-induced lipoprotein and serum oxidation."
|3.||Myeloid Leukemia (Leukemia, Myelocytic)
01/01/2013 - "The anti-tumor effect of R-Phycoerythrin (R-PE) from Porphyra haitanensis was studied using cell line HeLa as an in vitro model and Sarcoma-180 (S180) tumor-bearing mice as an in vivo model. "
02/01/2002 - "The experimental research of R-phycoerythrin subunits on cancer treatment: a new photosensitizer in PDT."
11/01/2007 - "An antibody to BerEP4, an epithelial cell marker expressed on >90% ovarian cancers, labeled with fluorescein, and an alpha-FR antibody labeled with antimouse-phycoerythrin have been used to label tumor cells, with a CD45-phycoerythrin-cyanine5 antibody used to exclude white blood cells from the analysis. "
11/01/1989 - "PMN were labeled with phycoerythrin-E (PE) via a granulocyte-specific monoclonal antibody (leu-M1) and mixed with fluorescein isothiocyanate-labeled K562 tumor cells sensitized with rabbit antiserum. "
12/01/2008 - "Efforts are underway to establish a preparation method for the phycoerythrin subunit (PE-sub) liposome, and enhance the cellular uptake and photodynamic therapy (PDT) effect on cancer cells. "
|5.||Crohn Disease (Crohn's Disease)
07/01/1991 - "Using two colour immunofluorescence with fluorescein isothiocyanate and phycoerythrin labelled monoclonal antibodies, multi-parameter flow cytometry was used to examine the antigenic characteristics of peripheral blood lymphocytes in whole blood of patients with ulcerative colitis and Crohn's disease who were not taking immunosuppressive drugs. "
10/01/1991 - "By using two-color immunofluorescence with fluorescein isothiocyanate (FITC) and phycoerythrin (PE)-labelled monoclonal antibodies and multiparameter flow cytometry, we investigated lamina propria lymphocyte subsets of patients with ulcerative colitis (UC) and Crohn's disease (CD). "
08/01/1991 - "Using two colour immunofluorescence with fluorescein isothiocyanate and phycoerythrin labelled monoclonal antibodies and multiparameter flow cytometry, we investigated the coexpression of CD4 and CD8 antigens on peripheral blood lymphocytes and lamina propria lymphocytes of patients with ulcerative colitis and Crohn's disease and normal control subjects. "
|3.||Immunoglobulin E (IgE)
|4.||Myeloblastin (Proteinase 3)
|10.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|1.||Photochemotherapy (Photodynamic Therapy)